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ABSTRACT
Introduction: Excessive portal venous pressure in the liver remnant is an independent factor in the occurrence of posthepatectomy 
liver failure and small-for-size syndrome. The baseline portal pressure prior to hepatectomy was not considered previously. The aim of 
this study is to assess the impact of portal pressure change during hepatectomy on the patient outcome.
Material and Methods: Prospective observational study including 30 patients subjected to intraoperative measurement of portal pres-
sure before and after hepatectomy. This variation was related to the patient outcome. Control group evaluation was assessed.  Patient, 
disease and procedure features were considered. The optimal cut-off of portal pressure variation was determined. Linear regression or 
logistic regression was applied to identify predictors of the outcome.
Results: The univariate analysis showed that portal pressure increase after hepatectomy was associated with coagulation impair-
ment in the first 30 postoperative days (p < 0.05), and with the occurrence of major complications (p = 0.01), namely hepatic failure 
(p = 0.041). The multivariate analysis showed that portal venous pressure increase ≥ 2 mmHg is an independent factor for worse 
outcomes.
Discussion: As in previous studies, this study concludes that, after hepatectomy, in addition to the functional liver remnant, other fac-
tors are responsible for deterioration of liver function and patient outcome, such as the portal pressure increase and the exposure to 
chemotherapy prior to hepatectomy. This work may influence the definition of future indications for portal influx modulation.
Conclusion: Patient outcomes are influenced by the portal venous pressure increase: an increment ≥ 2 mmHg after hepatectomy 
seems to increase the risk of major complications.
Keywords: Hepatectomy; Portal Pressure; Portal Vein
RESUMO
Introdução: O aumento da pressão venosa portal para o remanescente hepático é um fator independente para falência hepática 
após hepatectomia e síndrome small-for-size. Estudos anteriores não consideram o valor de pressão portal prévio à hepatectomia. 
O objetivo deste estudo é analisar o impacto da variação da pressão portal durante a hepatectomia na evolução clínica pós-operatória. 
Material e Métodos: Estudo observacional prospetivo, incluindo 30 doentes submetidos a medição intraoperatória da pressão portal 
antes e após hepatectomia, relacionando esta variação com a evolução clínica pós-operatória. Avaliação similar foi efetuada num 
grupo de controlo. Fatores relacionados com o doente, doença e procedimento foram considerados. Determinou-se o valor ideal de 
variação da pressão portal. Regressão linear ou logística foram aplicadas para identificar fatores preditores de evolução clínica.
Resultados: A análise univariada mostrou que um aumento de pressão portal após hepatectomia associa-se a deterioração da coa-
gulação nos primeiros 30 dias após hepatectomia (p < 0,05), a complicações major (p = 0,01) como a falência hepática após hepa-
tectomia (p = 0,041). A análise multivariada mostrou que um aumento de pressão portal ≥ 2 mmHg é um fator independente para a 
evolução clínica pós-operatória desfavorável.
Discussão: Após hepatectomia, para além do remanescente hepático funcional, outros fatores são responsáveis pela deterioração 
da função hepática e pela morbimortalidade, como o aumento da pressão portal e a exposição prévia a quimioterapia. Este trabalho 
contribui para a definição futura das indicações para modulação do influxo portal.
Conclusão: Um aumento de pressão portal ≥ 2 mmHg após hepatectomia parece agravar o risco de complicações major. 
Palavras-chave: Hepatectomia; Pressão Portal; Veia Porta
INTRODUCTION
Major hepatectomy (MH) is currently the standard treat-
ment for benign and malignant liver disease, allowing also 
collecting grafts in living donor liver transplantation (LDLT).1,2
Over the last years, there has been an increase in sur-
vival and more acceptable morbidity and mortality rates in 
patients undergoing MH or LDLT.3,4 However, despite this 
progress, the mortality rate after MH remains worrying, 
with liver failure being its main cause.1,5,6 Several studies 
suggest that hepatic failure after MH is due to reduced liver 
volume and hemodynamic changes, which increase oxida-
tive stress, leading to necrosis and apoptosis.7–12 Although 
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portal venous pressure (PVP) and flow play an important 
role in hepatic regeneration after hepatectomy, these rapid 
hemodynamic changes may lead to excessive portal venous 
pressure to the liver remnant, consequent sinusoidal injury, 
destruction of the hepatic parenchyma and hepatic dys-
function.7–11 A similar process has been described in LDLT, 
which allowed identifying small-for-size syndrome (SFSS) 
as an important clinical entity. More recently, the concept of 
‘small-for-flow’ based on the assumption that post-hepatec-
tomy liver failure (PHLF) and SFSS after LDLT would have 
the same origin, has been proposed: the excessive portal 
venous flow to the liver remnant.7
Several studies have shown the importance of PVP 
early assessment as an independent predictor for PHLF 
occurrence.1,7,8,11,13–16 However, few published studies attrib-
ute a cut-off of PVP, above which PHLF or SFSS become 
very likely. In addition, they do not consider other factors 
which influence intraoperative PVP, namely, the baseline 
PVP prior to hepatectomy.
The aim of this study is to assess the impact of PVP 
variation during hepatectomy on cytolysis, hepatic function, 
morbidity and mortality.
MATERIAL AND METHODS
Inclusion criteria and ethical authorization
Patients proposed for liver resection, without liver cir-
rhosis or anaesthetic contraindication, with a future liver 
remnant (FLR) > 30% and benign or malignant diagnosis 
were included in this study. All patients authorized the par-
ticipation through informed consent, approved by the Ethics 
Committee of the Vila Nova de Gaia/Espinho Hospital, 
which also approved the study protocol.
Sample characterization
The sample included 30 patients undergoing hepatecto-
my, randomly selected from January 2011 to April 2016. The 
patient features are shown in Table 1.
The FLR, defined as the percentage of functional hepat-
ic remnant after hepatectomy, was estimated, as previously 
described.17
Four patients underwent portal venous embolization, 
preceded by percutaneous biliary drainage of the liver 
remnant, as mentioned above.4 Twenty-one patients were 
previously or concomitantly subjected to metastasis ther-
moablation of the liver remnant. Mortality was defined as 
death within the first 90 days after hepatectomy. 
Control group
Fifteen patients, who underwent right hemicolectomy, 
were randomly chosen in the same period. This surgical 
procedure induces a significant and abrupt iatrogenic PVP 
increase without changing the remaining liver.
Measurement of portal venous pressure and surgical 
procedure
The hepatectomy techniques were performed according 
to previous description.18 PVP was measured before and 
after hepatectomy, by introducing a 1.4 Fr catheter into the 
portal vein, attached to the transducer that measures venous 
pressure during intraoperative monitoring. Central venous 
pressure was maintained below 5 mmHg in both measures.
Portal venous pressure variation
The variation of PVP, defined as the difference between 
the values obtained after and before the procedure shows an 
average value = 2.33 ± 3.7 mmHg and median = 1 mmHg.
Study endpoints
The main endpoint of this study is to relate the variation 
of PVP, before and after hepatectomy, with:
a) Variation of prothrombin time (PT) and internation-
al normalized ratio (INR), total bilirubin, albumin, 
aspartate transaminase, alanine aminotransferase, 
glutamic-oxalacetic transaminase (GOT), alkaline 
phosphatase (AP), lactic dehydrogenase (LDH), 
gama-glutamyltransferase (GGT) and creatinine, 
measured by serum assay in the last 15 preopera-
tive days, at 24 hours and at the 30th day of postop-
erative time.
b) Clavien-Dindo morbidity score.19
c) Presence of hepatic failure according to the ‘50–50 
criteria’5 and the International Study Group of Liver 
Surgery (IGSLS).6
d) Mortality defined by death within the first 90 postop-
erative days.
Several factors related to the patient, to the disease and 
to the surgical procedure that may influence the relation 
under analysis were considered, as showed in Table 1. 
In the control group undergoing right hemicolectomy, 
hepatic function and cytolysis were evaluated through 
the variables already mentioned in the group of patients 
subjected to hepatectomy. Similarly, other outcome factors 
were considered.
Statistical analysis
The evaluation of normal distribution of quantitative 
variables was done according to the Shapiro-Wilk test. The 
comparison of continuous variables between two independ-
ent groups was done according to the independent samples 
t-Student test or the Mann-Whitney U test. The χ2 test or 
the Fisher exact test was used for comparisons between 
categorical variables. For comparisons between ordinal or 
quantitative variables, the Rho-Spearman or the Pearson 
test were used.
The receiver operating characteristic (ROC) curve was 
applied to determine the optimal cut-off of the PVP variation, 
as a predictor of the outcome. Linear regression was applied 
to identify predictors of hepatic dysfunction and cytolysis. 
The significance check in the linear regression analysis was 
based on an F-test and the significance of single independ-
ent variables was assessed by a t-test. For the selection 
of variables in the multiple regression a stepwise approach 
was applied. To identify predictors of major complications 
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Table 1 – Clinical characteristics of the patients included
PVP < 2 PVP ≥ 2 p Total
n Mean(μ ± σ) % n
Mean
(μ ± σ) % n
Mean
(μ ± σ) %
Age 59.3 ± 12.6 66.1 ± 9.0 0.166 — 62.47 ± 11.42 –
Gender Female / Male 10/6 62.5/37.5 8/6 57.1/42.9 1.00 18/12 – 60/40
Previous infection 2 12.5 5 35.7 0.204 7 – 23.33
Diagnosis 0.675
   Benign or Pre-malignant 3 18.8 4 28.,6 7 – 23.33
   Malignant 13 81.3 10 71.4 23 – 76.67
Hepatitis B 1 6.7 0 0 1.00 1 – 3.33
Alcoholic consumption 2 13.3 0 0 0.483 2 – 6.67
Smoking 5 33.3 1 7.1 0.169 6 – 20
Diabetes mellitus 4 26.7 3 21.4 1.00 7 – 23.33
Body mass index 26.6 ± 5.1 26.95 ± 3.8 0.918 – 26.78 ± 4.48 –
Karnofsky score (%)
13 (100%)
2 (90%)
1 (80%)
8 (100%)
3 (90%)
3 (80%)
0.240 – !MED: 100 –
ASA* (median) 2 2 0.728 – 2 –
FLR** 0.69 ± 0.18 0.61 ± 0.18 0.257 – 0.65 ± 0.18 –
Surgical procedures
   Multiple MTX*** / 
   segmentectomy 2 0 2 – 6.67
   Bisegmentectomy 3 3 6 – 20
   Trisegmentectomy 2 1 3 – 10
   Left hepatectomy 3 2 5 – 16.67
   Left hepatectomy + 
   segmentectomy I 1 1 2 – 6.67
   Right hepatectomy 3 5 8 – 26.67
   Right hepatectomy + 
   segmentectomy I 1 0 1 – 3,33
   Central hepatectomy 1 1 2 – 6.67
   ALPPS± 0 1 1 – 3.33
Morbidity Mortality
   without complications 5 31.3 2 14.2 7 – 23.33
Hepatic failure 
   ISGLS criteria 4 0 4 13.33
   50–50 criteria 2 0 2 6.67
Clavien Dindo score
– Grade I 4 25 2 14.2 6 – 20
– Grade II 4 25 3 21.4 7 – 23.33
– Grade IIIA 1 6.3 3 21.4 4 – 13.33
– Grade IIIB 1 6.3 1 7.1 2 – 6.67
– Grade IV 1 6.3 0 0 1 – 3.33
– Grade V (mortality in the 
– first 90 days) 0 0 3 21.4 3 – 10
*ASA: American Society of Anaesthesiologists score; !MED: median; **FLR: future liver remnant; ***MTX: metastasectomies; ±ALLPS: 
associating liver partition and portal vein ligation for staged hepatectomy.
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or PHLF forward logistic regression (Wald test) was used. 
A significance of 0.05 was considered for all comparisons. 
RESULTS
Univariate analysis
In this model, the PVP increase was associated with a 
coagulation impairment at 24 hours (INR24 hours: r = 0.447, 
p = 0.013) and on the fifth day after hepatectomy (INR5: 
r = 0.379, p = 0.039; PT5: r = –0.387, p = 0.038), compared 
to preoperative evaluation, as shown in Table 2. On the 
30th postoperative day, the association between increased 
PVP after hepatectomy and coagulation impairment is still 
observed (INR30: r = 0.414, p = 0.032; PT30: r = –0.459, 
p = 0.01) (Table 2.) In addition, the PVP increase is relat-
ed to the serum GOT increase (r = 0.525, p = 0.007) and 
serum AP increment (r = 0.701, p = 0.0001) in the 30th day, 
enzymes whose concomitant serum assay is raised in the 
context of hepatic dysfunction (Table 2).
The PVP increase after hepatectomy is associated with 
the occurrence of major complications (p = 0.01). In addi-
tion, the PVP variation tends to increase with the appear-
ance of PHLF defined by the IGSLS criteria (p = 0.041), as 
shown in Table 2. In this sample, there was no association 
between the PVP increase after hepatectomy and PHLF, 
according to the ‘50–50 criteria’, nor with postoperative 
mortality (Table 2).
Considering the other factors that could interfere with 
the studied association, none revealed to influence the 
relation between the PVP variation and the outcome ana-
lysed. However, if we observe the influence of each factor 
on the outcome variables, we find that the decrease in 
FLR interferes with the coagulation impairment (INR24h: 
r = –0.492, p = 0.006; INR5: r = –0.474, p = 0.008). Besides 
that, chemotherapy prior to hepatectomy was associated 
with coagulation impairment in the fifth postoperative day 
(r = 0.362, p = 0.049). 
Multivariate analysis
In the multiple linear regression model (Table 3), when 
we analysed the cumulative effect of PVP variation during 
hepatectomy and FLR, we found that they influence the 
coagulation at 24 hours, accounting for 32.5% of the INR 
variance (r2 = 0.325, p < 0.01). The PVP increase after hepa-
tectomy causes an INR increment at 24 postoperative hours 
(ß = 0.385, p < 0.05), while, as expected, the FLR increase 
has an opposite effect on the INR (ß = –0.355, p < 0.05). 
In addition, the results show that PVP variation and 
exposure to chemotherapy (CHEMO) prior to hepatectomy 
lead to a cumulative coagulation impairment, accounting for 
35.8% of the INR variance on the 30th postoperative day 
(r2 = 0.423, p < 0.01), through a positive effect of both (PVP: 
ß = 0.538, p < 0.01) (CHEMO: ß = 0.423, p < 0.05) (Table 3). 
The results also show that the PVP and FLR variation 
influence the degree of hepatic cytolysis after hepatectomy: 
it accounts for 61.1% of the AP serum assay variance on 
the 30th postoperative day (r2 = 0.611, p < 0.001). While 
the former causes an AP serum increment (ß = 0.674, 
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Table 2 – Correlation between the PVP variation and the variation 
of the variables studied before and after hepatectomy
r 
(correlation)
p
(significance)
INR24 hours 0.447 0.013
PT24 hours –0.397 0.033
Ldh24 hours 0.542 0.005
INR5 0.379 0.039
PT5 –0.387 0.038
inr30 0.414 0.032
PT30 –0.459 0.01
AP 30 0.701 0.0001
gOt30 0.525 0.007
Clavien-Dindo 0.01
PHLF (ISGLS criteria) 0.041
PHLF (50–50 criteria) n.s.
Mortality n.s.
INR24 hours/5/30: variation of international normalized ratio be-
tween preoperative time and 24 hours, fifth and 30th postopera-
tive days; PT 24 hours/5/30: prothrombin time variation between 
preoperative time and 24 postoperative hours; LDH 24 hours: 
lactic dehydrogenase variation between preoperative time and 
24 postoperative hours; AP 30: alkaline phosphatase variation 
between preoperative time and 24 postoperative hours; GOT 30: 
glutamic-oxalacetic transaminase variation between preoperative 
time and 30th postoperative day; Clavien – Dindo: postoperative 
morbidity score; PHLF: posthepatectomy liver failure according to 
ISGLS criteria or ‘50–50’ criteria. Mortality: defined as death in the 
first postoperative 90 days.
Figure 1 – ROC (AUC = 0.69) used to define the PVP increment 
cut-off for the occurrence of major complications
1,0
0,8
0,6
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0,0
1,00,80,60,40,20,0
Se
ns
iti
vi
ty
ROC
1 – Specificity
ΔPVP = 1,5 mmHg
p < 0.001), the second has an opposite effect (ß = –0.305, 
p < 0.05). This evidence is corroborated by the similar effect 
of the PVP increase on serum GGT on the 30th postopera-
tive day (ß = 0.606; p < 0.01), being responsible for 36.8% 
of the serum GGT variance (r2 = 0.368; p < 0.01) (Table 3). 
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Table 3 – Multivariate analysis
MLRM! B EPB β r2
∇INR 24 hours/preoperative
   ∇PVP++
   FLR+++
0.056
–0.672
0.023
0.304
0.385*
–0.355*
0.325**
∇INR 30/ preoperative
   ∇PVP++
   Chemotherapy prior hepatectomy
0.032
0.025
0.01
0.01
0.538**
0.423*
0.358**
∇AP++++ 30/ preoperative
   ∇PVP++
   FLR+++
19.4
–97.8
3.97
44.1
0.674***
–0.305*
0.611***
SLRM! B EPB β r2
∇GGT+++++ 30/preoperative
   ∇PVP++ 43.3 11.8 0.606** 0.368**
∇INR5
   PVP ≥ 2/PVP < 2 0.15 0.058 0.45* 0.203*
LRM!! RR IC 95% p
Clavien-Dindo
   Previous infection
   PVP ≥ 2
3.1
0.124
0.369 – 26.1
0.018 – 0.837
0.297
0.032
∇: variation. !MLRM: Multiple linear regression model. !SLRM: Simple linear regression model. !!LRM: Logistic regression model. +RR: Risk 
ratio. ++PVP: Portal venous pressure. +++FLR: Future liver remnant.  ++++AP: alkaline phosphatase. +++++GGT: gamma-glutamyltransferase. 
!PVP ≥ 2/PVP < 2: Stratified PVP < 2 mm Hg or ≥ 2 mm Hg. *p < 0.05; **p < 0.01; ***p < 0.001.
PVP variation cut-off during hepatectomy
The ROC curve shows that a PVP increment after hepa-
tectomy greater than 1.5 mmHg is the optimal cut-off for the 
occurrence of major complications, with a sensitivity of 70% 
and specificity of 65% (AUC = 0.69), as shown in Fig. 1. 
By reclassifying the PVP variation as a binary variable 
(PVP < 2 mmHg and PVP ≥ 2 mmHg), in a univariate anal-
ysis, we confirm that patients undergoing hepatectomy and 
exhibiting a PVP increment ≥ 2 mmHg express a greater 
deterioration of the coagulation at 24 postoperative hours 
(INR24 hours: p = 0.006), which remains at the following 
time points (INR5: p < 0.029) (INR30: p = 0.033), compared 
to patients with a PVP increase < 2 mmHg. This greater 
coagulation impairment in the first 30 days after hepatecto-
my is confirmed by the serum LDH increase at 24 postop-
erative hours (p = 0.026) and by the serum AP increment 
on the 30th postoperative day (p = 0.001), in the group of 
patients exhibiting PVP ≥ 2 mmHg, as shown in Table 4. 
In the stepwise linear regression analysis, it is shown 
that PVP increment ≥ 2 mmHg is an independent factor 
for the worse coagulation impairment after hepatectomy, 
accounting for 20.3% of the INR increase on the fifth post-
operative day (r2 = 0.203; p < 0.05), as shown in Table 3. 
Moreover, it is shown, in a forward logistic regression model, 
that a PVP increment ≥ 2 mmHg after hepatectomy is also 
an independent factor for the occurrence of major complica-
tions, being clear that the patients with this condition have 
an 8.1% increased risk (OR = 0.124, p = 0.032) of major 
complications compared to patients with PVP < 2 mmHg 
(Table 3).
Control group
Patients in the control group, undergoing right hemi-
colectomy without hepatic resection, exhibit a coagulation 
impairment in the first 24 hours after surgery, expressed by 
the INR increase (p = 0.014) and by PT decrease (p = 0.008), 
compared to the preoperative assays. On the fifth and 30th 
postoperative days, coagulation improved, compared to the 
preoperative control. Furthermore, there is a serum albumin 
decrease in the first 24 hours, compared to the preoperative 
period (p = 0.001), which does not persist in the following 
time points.
If we analyse the cytolysis and the excretory and synthe-
sis hepatic functions, we do not detect significant variation 
in the first 30 postoperative days. 
DISCUSSION
This model demonstrates that PVP increase is a pre-
dictive factor of coagulation impairment, at 24 hours after 
hepatectomy, when analysed concomitantly with the future 
liver remnant. In addition, this coagulation impairment is 
maintained on the 30th postoperative day, if we consider the 
Table 4 – Univariate analysis of portal venous pressure as binary 
variable: PVP < 2 mm Hg versus PVP ≥ 2 mm Hg
PVP < 2 mm Hg PVP ≥ 2 mm Hg p
INR24 hours 0.41 ± 0.25 0.62 ± 0.45 0.006
INR 5 0.1 ± 0.11 0.2 ± 0.24 0.029
INR30 0.04 ± 0.08 0.12 ± 0.1 0.033
LDH 24 hours 68.4 ± 90.7 993 ± 1731 0.026
AP 30 36.8 ± 46.3 102.7 ± 73.6 0.001
INR24 hours/5/30: variation of international normalized ratio be-
tween preoperative time and 24 hours, fifth and 30th postoperative 
days; LDH 24 hours: lactic dehydrogenase variation between pre-
operative time and 24 postoperative hours; AP 30: alkaline phos-
phatase variation between preoperative time and 30th postopera-
tive day.
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joint influence of exposure to chemotherapy prior to hepa-
tectomy. This hepatic functional decrease is corroborated by 
an increase in serum GGT and AP on the 30th postoperative 
day, which are indicators of liver injury that are widely used 
in clinical practice. This association between increased 
PVP and hepatic functional deterioration also occurs in 
the control group in the first 24 hours, in which an increase 
in PVP is induced without associated hepatic resection, 
indicating that the increase in PVP has deleterious effects 
on the liver, in accordance with previous studies.1,7,8,11,13–16 
However, unlike patients undergoing hepatectomy, there 
is a coagulation recovery at the following evaluation time 
points and a concomitant absence of additional hepatic 
dysfunction, indicating that deterioration of hepatic function 
after hepatectomy is multifactorial. 
As in previous studies,1,3,20 this work supports the hypoth-
esis that the cause of liver function deterioration is not only 
the functional percentage of the remaining liver, but also 
other factors such as the PVP increase after hepatectomy 
and the exposure to chemotherapy prior to hepatectomy. 
Even though portal venous flow plays a significant role in 
liver regeneration, these quick hemodynamic changes can 
lead to excessive portal venous flow to the residual liver, 
which generates portal hyperperfusion. Several factors are 
implicated in the pathogenesis of this phenomenon, namely 
the increased production of reactive oxygen species and 
cytokines induced by hemodynamic changes which, by 
itself, leads to hepatocyte necrosis and apoptosis. Besides 
this, it is also reported that portal hyperperfusion destroys 
the hepatic sinusoidal network, by excessive shear forces 
on its walls, leading to periportal bleeding and endothelial 
destruction. Another explanation is based on the abrupt and 
excessive regenerative stimulus induced by portal hyperper-
fusion, which, particularly in the early hours, leads to exces-
sive hepatocyte proliferation not supported by an organized 
sinusoidal network to ensure adequate blood supply to the 
hepatocytes, thus compromising liver function.11
Previous investigations1,21 based on the measurement 
of PVP after hepatectomy or LDLT, attribute a post-hepatec-
tomy PVP cut-off of 20 or 21 mmHg, from which the risk of 
hepatic failure is higher. However, they do not consider the 
baseline PVP before hepatectomy. Currently, the underlying 
mechanisms to PVP variation after hepatectomy are poorly 
understood in humans. In addition, the PVP variability in 
the human model is unknown, such as all the factors that 
may influence it. Thus, the novelty of this study is the 
prediction of the occurrence of severe hepatic dysfunction 
after hepatectomy considering PVP variation before and 
after hepatectomy and not only a single measurement after 
hepatectomy. This problem becomes more important if, in 
the future, we could define which patients benefit from the 
intraoperative portal influx modulation procedure, which 
may be an effective strategy for preventing hepatic failure 
after hepatectomy.1,22 However, this model has some limita-
tions. One of them is the small sample size. Another prob-
lem is the selection of variables to perform the regression 
analysis, when a high number of independent variables that 
are candidates for the selection is present. To deal with this, 
a stepwise selection was performed. Eveb though stepwise 
regression analysis is popular, some authors consider that 
these methods are poor, because they may not identify sets 
of variables that fit well, even when such sets exist23 and 
a parameter estimates are likely to be too far away from 
zero.24 Nonetheless, despite these limitations, this model 
shows that a PVP increment ≥ 2 mmHg after hepatectomy 
worsens hepatic coagulation function during the first five 
postoperative days and carries an increased risk of major 
complications. In our opinion, this not only demonstrates 
the need to evaluate PVP variation intraoperatively, but 
may also influence other studies, contributing to the future 
definition of indications for portal influx modulation. 
CONCLUSION
PVP increase during hepatectomy influences the 
deterioration of liver function in the postoperative period. A 
PVP increase ≥ 2 mmHg after hepatectomy, compared to 
baseline, increases the risk of major complications.
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